| Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis S Arora, N Tyagi, A Bhardwaj, L Rusu, R Palanki, K Vig, SR Singh, ... Nanomedicine: Nanotechnology, Biology and Medicine 11 (5), 1265-1275, 2015 | 108 | 2015 |
| Phosphatase activity tunes two-component system sensor detection threshold BP Landry, R Palanki, N Dyulgyarov, LA Hartsough, JJ Tabor Nature communications 9 (1), 1433, 2018 | 86 | 2018 |
| Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery KL Swingle, MM Billingsley, SK Bose, B White, R Palanki, A Dave, ... Journal of Controlled Release 341, 616-633, 2022 | 36 | 2022 |
| Delivery technologies for in utero gene therapy R Palanki, WH Peranteau, MJ Mitchell Advanced drug delivery reviews 169, 51-62, 2021 | 29 | 2021 |
| Size is an essential parameter in governing the UVB-protective efficacy of silver nanoparticles in human keratinocytes R Palanki, S Arora, N Tyagi, L Rusu, AP Singh, S Palanki, JE Carter, ... BMC cancer 15, 1-7, 2015 | 28 | 2015 |
| Ionizable lipid nanoparticles for therapeutic base editing of congenital brain disease R Palanki, SK Bose, A Dave, BM White, C Berkowitz, V Luks, F Yaqoob, ... ACS nano 17 (14), 13594-13610, 2023 | 13 | 2023 |
| mRNA Lipid Nanoparticles for Ex Vivo Engineering of Immunosuppressive T Cells for Autoimmunity Therapies AS Thatte, AG Hamilton, BE Nachod, AJ Mukalel, MM Billingsley, ... Nano Letters 23 (22), 10179-10188, 2023 | 3 | 2023 |
| Design and evaluation of a low-cost piezoelectric device for remote diagnosis of respiratory diseases R Palanki, J Poiroux, S Palanki International Journal Bioautomation 19 (4), 521, 2015 | 2 | 2015 |
| Comment on: Premature delivery in the domestic sow in response to in utero delivery of AAV9 to fetal piglets A Dave, CL Berkowitz, VL Luks, BM White, R Palanki, MD Carpenter, ... Gene Therapy 30 (3), 232-235, 2023 | 1 | 2023 |
| Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length K Mrksich, MS Padilla, RA Joseph, EL Han, D Kim, R Palanki, J Xu, ... Journal of Biomedical Materials Research Part A, 2024 | | 2024 |
| In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors X Han, J Xu, Y Xu, MG Alameh, L Xue, N Gong, R El-Mayta, R Palanki, ... Nature Communications 15 (1), 1762, 2024 | | 2024 |
| Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood–Brain Barrier Transfection and Crossing EL Han, MS Padilla, R Palanki, D Kim, K Mrksich, JJ Li, S Tang, IC Yoon, ... Nano Letters, 2024 | | 2024 |
| siRNA lipid nanoparticles for CXCL12 silencing modulate brain immune response during Zika infection PAC Costa, WN da Silva, PHDM Prazeres, HAS Ferreira, NJA da Silva, ... Biomedicine & Pharmacotherapy 170, 115981, 2024 | | 2024 |
| Orphan drugs P Menon, R Palanki, S Dasani, SK Bose Translational Surgery, 529-534, 2023 | | 2023 |
| Drug discovery and development R Palanki, SK Bose Translational Surgery, 35-41, 2023 | | 2023 |
| Biopharmaceuticals S Dasani, R Palanki, P Menon, SK Bose Translational Surgery, 535-538, 2023 | | 2023 |
| A (Controlled) Spill of IL2 for Localized Treatment of Mesothelioma R Palanki, KL Swingle, MJ Mitchell Clinical Cancer Research 28 (23), 5010-5012, 2022 | | 2022 |
| Drug delivery technologies for fetal, neonatal, and maternal therapy R Palanki, WH Peranteau, MJ Mitchell Advanced drug delivery reviews 189, 114523, 2022 | | 2022 |
